Edition:
United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

3.28USD
3:59pm EST
Change (% chg)

$-0.12 (-3.68%)
Prev Close
$3.40
Open
$3.40
Day's High
$3.40
Day's Low
$3.25
Volume
45,672
Avg. Vol
139,236
52-wk High
$13.00
52-wk Low
$2.92

Select another date:

Mon, Nov 6 2017

BRIEF-Ecor1 Capital reports 7.4% passive stake in Immune Design

* Ecor1 Capital Llc reports 7.4% passive stake in Immune Design Corp as of Oct 25 - SEC filing‍​ Source text: (http://bit.ly/2zkI4Ki) Further company coverage:

BRIEF-Immune Design reports Q3 loss per share of $0.52

* IMMUNE DESIGN REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design prices offering of 19.5 million shares at $4.10 per share​

* Immune Design prices $80.0 million public offering of common stock

BRIEF-Immune Design proposes public offering of common stock

* Immune Design announces proposed public offering of common stock

BRIEF-Immune design announces G100’s receipt of orphan drug designation by EMA

* Immune design announces G100’S receipt of orphan drug designation by the EMA for the treatment of follicular non-Hodgkin’s lymphoma Source text for Eikon: Further company coverage:

BRIEF-Immune Design gets positive FDA feedback on Phase 3 clinical trial design for CMB305

* Immune Design announces positive FDA feedback on Phase 3 clinical trial design for CMB305 in synovial sarcoma patients

BRIEF-Bain Capital Public Equity Management LLC reports a 5.07 pct passive stake in Immune Design

* Bain Capital Public Equity Management LLC reports a 5.07 percent passive stake in Immune Design Corp as of September 29, 2017 - SEC Filing‍​ Source text:(http://bit.ly/2xnRteZ) Further company coverage:

Select another date: